Clinical trials sponsored by The First Hospital of Jilin University
8
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 2 2Phase 4 1Not applicable 5
Conditions studied
Recruiting trials led by The First Hospital of Jilin University
- Effect of Gut Microbiota and Its Metabolites on the Efficacy of Immunotherapy in Metastatic Colorectal Cancer
- Nefecon and Ambrisentan in IgA Nephropathy
- New Second-Line Combo Therapy for MSS Metastatic Colorectal Cancer
- Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery
- Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
- The Diagnostic Value of Subharmonic Imaging Technology Combined With Liver Stiffness and Platelet Count for High-risk Esophageal and Gastric Varices in Patients With Liver Cirrhosis
- The Impact of Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis on Stoma-free Survival in Low Rectal Anal-preserving Surgery
- Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial
Common questions
How many trials is The First Hospital of Jilin University recruiting for?
The First Hospital of Jilin University is the lead sponsor of 8 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.